Alpha 2.0
Login Register
» Articles » PMID: 36707069

Pathological Trajectory in the Ts65Dn Model of Down Syndrome

Overview
Journal Aging (Albany NY)
Specialty Geriatrics
Date 2023 Jan 27
PMID 36707069
Authors
Savannah Tallino
Wendy Winslow
Ramon Velazquez
Affiliations
Soon will be listed here.
Citing Articles

Ultrasonic vocalization phenotypes in the Ts65Dn and Dp(16)1Yey mouse models of Down syndrome.

Glass T, Lenell C, Fisher E, Yang Q, Connor N Physiol Behav. 2023; 271:114323.

PMID: 37573959 PMC: 10592033. DOI: 10.1016/j.physbeh.2023.114323.

References
1.
Cataldo A, Petanceska S, Peterhoff C, Terio N, Epstein C, Villar A . App gene dosage modulates endosomal abnormalities of Alzheimer's disease in a segmental trisomy 16 mouse model of down syndrome. J Neurosci. 2003; 23(17):6788-92. PMC: 6740714. View
2.
Kelley C, Powers B, Velazquez R, Ash J, Ginsberg S, Strupp B . Sex differences in the cholinergic basal forebrain in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease. Brain Pathol. 2013; 24(1):33-44. PMC: 4220609. DOI: 10.1111/bpa.12073. View
3.
Tallino S, Winslow W, Bartholomew S, Velazquez R . Temporal and brain region-specific elevations of soluble Amyloid-β in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease. Aging Cell. 2022; 21(4):e13590. PMC: 9009111. DOI: 10.1111/acel.13590. View
4.
Davisson M, Schmidt C, Reeves R, Irving N, Akeson E, Harris B . Segmental trisomy as a mouse model for Down syndrome. Prog Clin Biol Res. 1993; 384:117-33. View
5.
Granholm A, Sanders L, Crnic L . Loss of cholinergic phenotype in basal forebrain coincides with cognitive decline in a mouse model of Down's syndrome. Exp Neurol. 2000; 161(2):647-63. DOI: 10.1006/exnr.1999.7289. View